In silico study of peptide inhibitors against BACE 1
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ahrens VM, Bellmann-Sickert K, Beck-Sickinger AG (2012) Peptides and peptide conjugates: therapeutics on the upward path. Future Med Chem 4(12):1567–1586
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215:403–410
Avan I, Hall CD, Katritzky AR (2014) Peptidomimetics via modifications of amino acids and peptide bonds. Chem Soc Rev 43(10):3575–3594
Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M (2012) An integrated encyclopedia of DNA elements in the human genome. Nature 489(7414):57–74
Blattner FR, Plunkett G, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y (1997) The complete genome sequence of Escherichia coli K-12. Science 277(5331):1453–1462
Brookmeyer R, Gray S, Kawas C (1998) Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset. Am J Public Health 88(9):1337–1342
Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement 3(3):186–191
Craik DJ, Fairlie DP, Liras S, Price D (2013) The future of peptide-based drugs. Chem Biol Drug Des 81(1):136–147
De Castro E, Sigrist CJ, Gattiker A, Bulliard V, Langendijk-Genevaux PS, Gasteiger E, Bairoch A, Hulo N (2006) ScanProsite: detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins. Nucl Acids Res 34:362–365
Dhar PK, Thwin CS, Tun K, Tsumoto Y, Maurer-Stroh S, Eisenhaber F, Surana U (2009) Synthesizing non-natural parts from natural genomic template. J Biol Eng 3:2
Dinger ME, Pang KC, Mercer TR, Mattick JS (2008) Differentiating protein-coding and non coding RNA: challenges and ambiguities. PLoS Comput Biol 4(11):e1000176
Dundas J, Ouyang Z, Tseng J, Binkowski A, Turpaz Y, Liang J (2006) CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucl Acids Res 34:116–118
Dutot L, Lecorche P, Burlina F, Marquant R, Point V, Sagan S, Chassaing G, Mallet JM, Lavielle S (2009) Glycosylated cell-penetrating peptides and their conjugates to a proapoptotic peptide: preparation by click chemistry and cell viability studies. J Chem Biol 3:51–65
Falciani C, Lozzi L, Pini A, Bracci L (2005) Bioactive peptides from libraries. Chem Biol 12(4):417–426
Fernández-Llamazares AI, Adan J, Mitjans F, Spengler J, Albericio F (2014) Tackling lipophilicity of peptide drugs: replacement of the backbone N-methyl group of Cilengitide by N-oligoethylene glycol (N-OEG) chains. Bioconjug Chem 25(1):11–17
Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A (2003) ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucl Acids Res 31:3784–3788
Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, Bairoch A (2005) Protein identification and analysis tools on the ExPASy server. In: Walker JM (ed) The proteomics protocols handbook. Humana Press, New York, pp 571–607
Gauthier MA, Klok HA (2008) Peptide/protein-polymer conjugates: synthetic strategies and design concepts. Chem Commun (Camb) 21(23):2591–2611
Geldenhuys WJ, Van der Schyf CJ (2013) Rationally designed multi-targeted agents against neurodegenerative diseases. Curr Med Chem 20(13):1662–1672
Gentilucci L, De Marco R, Cerisoli L (2010) Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization. Curr Pharm Des 16(28):3185–3203
Gui J, Liu B, Cao G, Lipchik AM, Perez M, Dekan Z, Mobli M, Daly NL, Alewood PF, Parker LL, King GF, Zhou Y, Jordt SE, Nitabach MN (2014) A tarantula-venom peptide antagonizes the TRPA1 nociceptor ion channel by binding to the S1–S4 gating domain. Curr Biol 24(5):473–483
Hamada Y, Ishiura S, Kiso Y (2012) BACE1 inhibitor peptides: can an infinitely small kcat value turn the substrate of an Enzyme into its inhibitor? ACS Med Chem Lett 3(3):193–197
Han TS, Teichert RW, Olivera BM, Bulaj G (2008) Conus venoms—a rich source of peptide-based therapeutics. Curr Pharm Des 14(24):2462–2479
Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256(5054):184–185
Hong L, Koelsch G, Lin X, Wu S, Terzyan S, Ghosh AK, Zhang XC, Tang J (2000) Structure of the protease domain of memapsin 2 (β-Secretase) complexed with inhibitor. Science 290(5489):150–153
Hruby VJ, Cai M (2013) Design of peptide and peptidomimetic ligands with novel pharmacological activity profiles. Annu Rev Pharmacol Toxicol 53:557–580
Joshi M, Shankar VK, Poovaiah T, Ingle K, Dhar PK (2013) Discovering novel anti-malarial peptides from the not-coding genome—a working hypothesis. Curr Synth Syst Biol 1:103
Kageyama Y, Kondo T, Hashimoto Y (2011) Coding vs non-coding: translatability of short ORFs found in putative non-coding transcripts. Biochimie 93:1981–1986
Kaspar AA, Reichert JM (2013) Future directions for peptide therapeutics development. Drug Discov Today 18(17–18):807–817
Lahiri DK, Farlow MR, Greig NH, Sambamurti K (2002) Current drug targets for Alzheimer’s disease treatment. Drug Dev Res 56:267–281
Li H, Aneja R, Chaiken I (2013) Click chemistry in peptide-based drug design. Molecules 18:9797–9817
Long JM, Lahiri DK (2011) Current drug targets for modulating Alzheimer’s amyloid precursor protein: role of specific micro-RNA species. Curr Med Chem 18(22):3314–3321
Lorber D (2013) GLP-1 receptor agonists: effects on cardiovascular risk reduction. Cardiovasc Ther 31(4):238–249
Mashiach E, Schneidman-Duhovny D, Andrusier N, Nussinov R, Wolfson HJ (2008) FireDock: a web server for fast interaction refinement in molecular docking. Nucl Acids Res 36:229–232
Mason JM (2010) Design and development of peptides and peptide mimetics as antagonists for therapeutic intervention. Future Med Chem 2(12):1813–1822
Meloen R, Timmerman P, Langedijk H (2004) Bioactive peptides based on diversity libraries, supramolecular chemistry and rational design: a new class of peptide drugs. Introduction. Mol Divers 8(2):57–59
Menschaert G, Vandekerckhove TT, Baggerman G, Schoofs L, Luyten W, Van Criekinge W (2010) Peptidomics coming of age: a review of contributions from a bioinformatics angle. J Proteome Res 9(5):2051–2061
Merrifield RB (1963) Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J Am Chem Soc 85(14):2149–2154
Niu Y, Gao H, Xu F, Wang C, Liu P, Yang G, Sun Q, Xu P (2012) Synthesis, in vitro biological evaluation and molecular docking studies of benzimidamides as potential BACE1 inhibitors. Chem Biol Drug Des 80(5):775–780
Pandey R, Singh AV, Pandey A, Tripathi P, Majumdar SK, Nath LK (2009) Protein and peptide drugs: a brief review. Res J Pharm Tech 2(2):228–233
Pinelli NR, Hurren KM (2011) Efficacy and safety of long-acting glucagon-like peptide-1 receptor agonists compared with exenatide twice daily and sitagliptin in type 2 diabetes mellitus: a systematic review and meta-analysis. Ann Pharmacother 45(7–8):850–860
Raghavan R, Groisman EA, Ochman H (2011) Genome-wide detection of novel regulatory RNAs in E. coli. Genome Res 21(9):1487–1497
Rodríguez AA, Salceda E, Garateix AG, Zaharenko AJ, Peigneur S, López O, Pons T, Richardson M, Díaz M, Hernández Y, Ständker L, Tytgat J, Soto E (2014) A novel sea anemone peptide that inhibits acid-sensing ion channels. Peptides 53:3–12
Saez NJ, Senff S, Jensen JE, Er SY, Herzig V, Rash LD, King GF (2010) Spider-venom peptides as therapeutics. Toxins (Basel) 2(12):2851–2871
Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ (2005) PatchDock and SymmDock: servers for rigid and symmetric docking. Nucl Acids Res 33:363–367
Sciarretta KL, Gordon DJ, Meredith SC (2006) Peptide-based inhibitors of amyloid assembly. Methods Enzymol 413:273–312
Shidhi PR, Nair AS, Suravajhala P (2014) Identifying pseudogenes from hypothetical proteins for making synthetic proteins. Syst Synth Biol 8(2):169–171
Speck-Planche A, Kleandrova VV, Luan F, Cordeiro MN (2013) Multi-target inhibitors for proteins associated with Alzheimer: in silico discovery using fragment-based descriptors. Curr Alzheimer Res 10(2):117–124
Strub JM, Goumon Y, Lugardon K, Capon C, Lopez M, Moniatte M, Van Dorsselaer A, Aunis D, Metz-Boutigue MH (1996) Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173–194 from bovine adrenal medullary chromaffin granules. J Biol Chem 271(45):28533–28540
Thundimadathil J (2012) Cancer treatment using peptides: current therapies and future prospects. J Amino Acids 2012:1–13. doi: 10.1155/2012/967347
Venter JC, Adams MD, Myers EW et al (2001) The sequence of the human genome. Science 291(5507):1304–1351
Verdine GL, Hilinski GJ (2012) Stapled peptides for intracellular drug targets. Methods Enzymol 503:3–33
Viayna E, Sabate R, Muñoz-Torrero D (2013) Dual inhibitors of β-amyloid aggregation and acetylcholinesterase as multi-target anti-Alzheimer drug candidates. Curr Top Med Chem 13(15):1820–1842
Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M (2010) Synthetic therapeutic peptides: science and market. Drug Discov Today 15(1–2):40–56
Wang Q, Yu X, Li L, Zheng J (2014) Inhibition of amyloid-β aggregation in Alzheimer’s disease. Curr Pharm Des 20(8):1223–1243
Xu Y, Li MJ, Greenblatt H, Chen W, Paz A, Dym O, Peleg Y, Chen T, Shen X, He J, Jiang H, Silman I, Sussman JL (2012) Flexibility of the flap in the active site of BACE1 as revealed by crystal structures and molecular dynamics simulations. Acta Crystallogr D Biol Crystallogr 68(1):13–25
Yan R, Vassar R (2014) Targeting the β secretase BACE1 for Alzheimer’s disease therapy. Lancet Neurol 13(3):319–329
Yeon SW, Jeon YJ, Hwang EM, Kim TY (2007) Effects of peptides derived from BACE1 catalytic domain on APP processing. Peptides 28(4):838–844